Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells

Published:2011-12 Issue:12 Volume:82 Page:1884-1890
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Yoshida Kozue,Nagai Tadashi,Ohmine Ken,Uesawa Mitsuyo,Sripayap Piyanuch,Ishida Yoji,Ozawa Keiya

Funder

Ministry of Education, Culture, Sports, Science and Technology, Japan

Japan Leukemia Research Fund

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference27 articles.

1. Leukemia, an effective model for chemical biology and target therapy;Chen;Acta Pharmacol Sin,2007

2. Treatment selection after imatinib resistance in chronic myeloid leukemia;Jabbour;Target Oncol,2009

3. Aurora kinases dawn as cancer drug targets;Sausville;Nat Med,2004

4. Roles of Aurora kinases in mitosis and tumorigenesis;Fu;Mol Cancer Res,2007

5. The Aurora kinase family in cell division and cancer;Vader;Biochim Biophys Acta,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aurora kinase: An emerging potential target in therapeutics;Protein Kinase Inhibitors;2022

2. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution;Cancer Letters;2019-01

3. Drug Resistance in Cancer and Role of Nanomedicine-Based Natural Products;Bioactive Natural Products for the Management of Cancer: from Bench to Bedside;2019

4. Co-targeting Aurora kinase A and Bcl-2 synergistically inhibits the viability in double-hit lymphoma cells;Translational Cancer Research;2017-08

5. Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects;Materials Science and Engineering: C;2016-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3